ArticleDrug design, development and therapy2019

miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGB1-Dependent Autophagy Pathways.

Yan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.